Stroke Volume

"Stroke Volume" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

The amount of BLOOD pumped out of the HEART per beat, not to be confused with cardiac output (volume/time). It is calculated as the difference between the end-diastolic volume and the end-systolic volume.

Descriptor ID	D013318
MeSH Number(s)	E01.370.370.380.150.700 G09.330.380.124.882
Concept/Terms	Stroke Volume Stroke Volume Stroke Volumes Volume, Stroke Volumes, Stroke Ventricular End-Systolic Volume Ventricular End-Systolic Volume End-Systolic Volume, Ventricular End-Systolic Volumes, Ventricular Ventricular End Systolic Volume Ventricular End-Systolic Volumes Volume, Ventricular End-Systolic Volumes, Ventricular End-Systolic Ventricular Ejection Fraction Ventricular Ejection Fraction Ejection Fraction, Ventricular Ejection Fractions, Ventricular Fraction, Ventricular Ejection Fractions, Ventricular Ejection Ventricular Ejection Fractions Ventricular End-Diastolic Volume Ventricular End-Diastolic Volume End-Diastolic Volume, Ventricular End-Diastolic Volumes, Ventricular Ventricular End Diastolic Volume Ventricular End-Diastolic Volumes Volume, Ventricular End-Diastolic Volumes, Ventricular End-Diastolic

Below are MeSH descriptors whose meaning is more general than "Stroke Volume".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Diagnosis [E01]
Diagnostic Techniques and Procedures [E01.370]
Diagnostic Techniques, Cardiovascular [E01.370.370]
Heart Function Tests [E01.370.370.380]
Cardiac Output [E01.370.370.380.150]
Stroke Volume [E01.370.370.380.150.700]
Biological Sciences [G]
Circulatory and Respiratory Physiological Phenomena [G09]
Cardiovascular Physiological Phenomena [G09.330]
Hemodynamics [G09.330.380]
Cardiac Output [G09.330.380.124]
Stroke Volume [G09.330.380.124.882]

Below are MeSH descriptors whose meaning is related to "Stroke Volume".

Below are MeSH descriptors whose meaning is more specific than "Stroke Volume".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Stroke Volume" by people in this website by year, and whether "Stroke Volume" was a major or minor topic of these publications.

Bar chart showing 211 publications over 30 distinct years, with a maximum of 13 publications in 2022 and 2024

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	0	2	2
1998	1	2	3
1999	0	1	1
2000	0	2	2
2001	1	1	2
2002	0	2	2
2003	1	3	4
2004	1	7	8
2005	0	7	7
2006	3	4	7
2007	2	7	9
2008	2	6	8
2009	4	6	10
2010	1	9	10
2011	1	4	5
2012	0	3	3
2013	4	7	11
2014	4	3	7
2015	4	3	7
2016	3	6	9
2017	2	3	5
2018	3	4	7
2019	3	6	9
2020	2	8	10
2021	2	10	12
2022	0	13	13
2023	0	12	12
2024	4	9	13
2025	1	7	8
2026	0	5	5

Below are the most recent publications written about "Stroke Volume" by people in Profiles.

Hegde SM, Wang X, Bhatia A, Peña-Peña ML, Sherrid MV, Figueiredo EL, Arad M, Barriales-Villa R, Choudhury L, Claggett BL, Coats CJ, de Barros Correia E, Costabel JP, Elliott PM, Silva Enciso JE, Garcia-Pavia P, Ge J, Ho CY, Lakdawala NK, Lewis GD, Maron MS, Martinez MW, Masri A, Maurer MS, Michels M, Mitter SS, Pino Moreno JE, Nagy V, Olivotto I, Owens AT, Poulsen SH, Rader F, Rowin EJ, Ruda M, Schulze PC, Sikand N, Spertus JA, Zhao X, Divanji PH, Heitner SB, Jacoby DL, Kupfer S, Malik FI, Salazar-Mendiguchía J, Wohltman A, Zhuo S, Solomon SD. Effect of Aficamten on Cardiac Structure and Function in Patients With Symptomatic Nonobstructive Hypertrophic Cardiomyopathy. Circulation. 2026 Oct 20; 154(16):1563-1576.

View in: PubMed
Schulz A, Maron MS, Peng LW, Maron BA, Amyar A, Ngo L, Olivotto I, Chan RH, Manning WJ, Rowin EJ, Nezafat R. Clinical Course and Predictors of Heart Failure in Asymptomatic Obstructive Hypertrophic Cardiomyopathy. J Am Heart Assoc. 2026 07 07; 15(13):e048066.

View in: PubMed
Tower-Rader A, Masri A, Nassif ME, Abraham TP, Barriales-Villa R, Choudhury L, Cooper RM, Elliott PM, Maron MS, Olivotto I, Oreziak A, Owens AT, Solomon SD, Heitner SB, Jacoby DL, Kupfer S, Liu X, Malik FI, Melloni C, Simkins TJ, Wei J, Saberi S. Aficamten in symptomatic obstructive hypertrophic cardiomyopathy: the FOREST-HCM long-term study. Eur Heart J. 2026 Jun 23; 47(24):3120-3131.

View in: PubMed
Kramer CM, Kolm P, DiMarco JP, Desai MY, Ho CY, Kwong RY, Dolman SF, Desvigne-Nickens P, Geller N, Kim DY, Schulz-Menger J, Friedrich MG, Maron MS, Appelbaum E, Link MS, Francis GS, Greenberg B, Jerosch-Herold M, Piechnik S, Mahmod M, Raman B, Jacoby DL, Baldassare LA, White JA, Chiribiri A, Helms AS, Choudhury L, Michels M, Bradlow WM, Salerno M, Heitner SB, Masri A, Prasad SK, Mohiddin SA, Plein S, Madias C, Mahrholdt H, Bucciarelli-Ducci C, Nightingale AK, Weinsaft JW, Kim HW, McCann GP, van Rossum A, Germans T, Williamson EE, Geske JB, Flett AS, Dawson D, Mongeon FP, Olivotto I, Crean AM, Woo A, Owens AT, Anderson L, Sharma S, Biagini E, Newby DE, Andre F, Berry C, Kim B, Larose E, Abraham TP, Hays AG, Sherrid MV, Gelfand EV, Nagueh SF, Rimoldi O, Camici P, Elstein E, Autore C, Watkins H, Weintraub WS, Neubauer S. Predictors of Long-Term Outcomes in Hypertrophic Cardiomyopathy: The NHLBI HCM Registry. JAMA. 2026 Jun 09; 335(22):1959-1969.

View in: PubMed
Eerdekens R, Johnson NP, Adrichem R, van Mieghem NM, Eftekhari A, Kakouros N, Demandt JPA, Farissi ME, Vervaat FE, Houthuizen P, Felix SEA, Bouwmeester S, van 't Veer M, Johnson DT, Gould KL, Tonino PAL. Clinical outcomes and haemodynamic response after blinded stress assessment of moderate aortic stenosis. EuroIntervention. 2026 Mar 16; 22(6):e347-e357.

View in: PubMed
Kim JH, Kiernan MS. Predictors of Left Ventricular Reverse Remodeling in Heart Failure with Reduced Ejection Fraction. Curr Heart Fail Rep. 2025 Nov 14; 22(1):39.

View in: PubMed
Schulz A, Wallace TE, Chow K, Bi X, Amyar A, Rodriguez J, Ghanbari F, Maron MS, Rowin EJ, Kellmann P, Manning WJ, Nezafat R. Quantitative myocardial blood flow and perfusion reserve with exercise cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2025; 27(2):101988.

View in: PubMed
Hegde SM, Wang X, Garcia-Pavia P, Getchevski S, Masri A, Merkely B, Nassif ME, Peña-Peña ML, Barriales-Villa R, Bilen O, Burroughs M, Claggett B, Costabel JP, Correia EB, Dybro AM, Elliott P, Lakdawala NK, Mann A, Maron MS, Nair A, Poulsen SH, Reant P, Schulze PC, Wang A, Sohn R, Berhane I, Heitner SB, Jacoby DL, Kupfer S, Malik FI, Wohltman A, Fifer MA, Solomon SD. Effect of Aficamten Compared With Metoprolol on Echocardiographic Measures in Symptomatic Obstructive Hypertrophic Cardiomyopathy: MAPLE-HCM. J Am Coll Cardiol. 2025 Dec 16; 86(24):2452-2467.

View in: PubMed
Mihos CG, Liu JE, Anderson KM, Pernetz MA, O'Driscoll JM, Aurigemma GP, Ujueta F, Wessly P. Speckle-Tracking Strain Echocardiography for the Assessment of Left Ventricular Structure and Function: A Scientific Statement From the American Heart Association. Circulation. 2025 Sep 09; 152(10):e96-e109.

View in: PubMed
Saberi S, Abraham TP, Choudhury L, Barriales-Villa R, Elliott PM, Nassif ME, Oreziak A, Owens AT, Tower-Rader A, Rader F, Garcia-Pavia P, Olivotto I, Coats CJ, Fifer MA, Sherrid MV, Solomon SD, Watkins H, Heitner SB, Jacoby DL, Kupfer S, Malik FI, Melloni C, Meng L, Wei J, Maron MS, Masri A. Aficamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy: 48-Week Results From FOREST-HCM. JACC Heart Fail. 2025 Aug; 13(8):102496.

View in: PubMed

People

Explore

Similar Concepts

Top Journals